| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/03/2003 | WO2003013227A9 Yield-related polynucleotides and polypeptides in plants |
| 07/03/2003 | WO2003008583A3 Novel compositions and methods for cancer |
| 07/03/2003 | WO2002101009A3 Structural and cytoskeleton-associated proteins |
| 07/03/2003 | WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 07/03/2003 | WO2002090991A3 Proteins and genes for diagnosis and treatment of erbb2-related cancer |
| 07/03/2003 | WO2002090495A8 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 07/03/2003 | WO2002090383A3 M. catarrhalis antigens |
| 07/03/2003 | WO2002083080A9 Method of treating arthritis using lentiviral vectors in gene therapy |
| 07/03/2003 | WO2002081691A3 Abcg5 and abcg8: compositions and methods of use |
| 07/03/2003 | WO2002074802A3 Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 07/03/2003 | WO2002072616A3 Transfection complexes |
| 07/03/2003 | WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor |
| 07/03/2003 | WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto |
| 07/03/2003 | WO2002059604A3 Diagnosis and treatment of multiple sclerosis |
| 07/03/2003 | WO2002057468A3 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 07/03/2003 | WO2002057305A3 A gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages |
| 07/03/2003 | WO2002050279A3 Nucleic acid-associated proteins |
| 07/03/2003 | WO2002046408A3 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/03/2003 | WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins |
| 07/03/2003 | WO2002040668A3 Proteins and dna sequences underlying these proteins used for treating inflammations |
| 07/03/2003 | WO2002036761A3 Compositions and methods for the diagnosis of cancer |
| 07/03/2003 | WO2002028998A3 Chlamydia pmp proteins, gene sequences and uses thereof |
| 07/03/2003 | WO2002026804A3 84241, a human ring finger family member and uses thereof |
| 07/03/2003 | WO2002026789A9 Nucleotide sequences mediating male fertility and method of using same |
| 07/03/2003 | WO2002024888A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | WO2002024744A3 49938, a human phospholipid transporter and uses therefor |
| 07/03/2003 | WO2002024733A3 Human polynucleotides and polypeptides encoded thereby |
| 07/03/2003 | WO2002022801A9 Mammalian receptor genes and uses |
| 07/03/2003 | WO2002020049A3 Eiav chimeric vaccine and diagnostic |
| 07/03/2003 | WO2002016599A3 Proteins and nucleic acids encoding same |
| 07/03/2003 | WO2002012447B1 Isolation and use of solid tumor stem cells |
| 07/03/2003 | WO2002008289A3 Novel proteins and nucleic acids encoding same |
| 07/03/2003 | WO2002008281A3 Bstp-cad protein and related reagents and methods of use thereof |
| 07/03/2003 | WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/03/2003 | WO2001098365A3 Peptide and polypeptide inhibitors of complement c1s |
| 07/03/2003 | WO2001083750A9 Dendritic cell co-stimulator molecules |
| 07/03/2003 | US20030126647 Method for inducing seed development by down-regulating expression of the FIS2 gene |
| 07/03/2003 | US20030126646 Nuclear fertility restorer genes and methods of use in plants |
| 07/03/2003 | US20030126644 Protocols for the generation of high yield, super productive transgenic plants disturbed in ran/ran-binding protein mediated cellular process |
| 07/03/2003 | US20030126642 Using the polycomb proteins fertilization independent endosperm (FIE) and medea (MEA) for controlling activities of non-endosperm tissues such as floral meristem |
| 07/03/2003 | US20030126638 Hap2-like transcription factor for use in adjusting lipid expression, phenotype and biosynthesis in crops such as corn, soybean and wheat; antisense agents; gene expression inhibition; leafy cotyledon-1 activator protein (lec1) |
| 07/03/2003 | US20030126637 Conferring antiviral, bactericidal and fungicidal infection activity monocotyledonous plants |
| 07/03/2003 | US20030126633 Genetically engineered potato which produces increased concentration of glucans/polysaccharides through antisense inhibition of branching enzymes and R1 protein |
| 07/03/2003 | US20030126631 Preparation of heterologous proteins on oil bodies |
| 07/03/2003 | US20030126628 Avian oviduct regulatory sequences for controlling expression of interferon in transgenic cells; bioreactors |
| 07/03/2003 | US20030126627 Beta amyloid precursor protein linked to muscle specific promoter (creatine kinase) for diagnosis and treatment of age related muscle disorders; screening for compounds which reduce beta amyloid protein proteolytic fragments |
| 07/03/2003 | US20030126624 Chimeric DNA-binding proteins |
| 07/03/2003 | US20030125718 Multiple beam laser sculpting system and method |
| 07/03/2003 | US20030125540 Cytokine thymotaxin; tumor necrosis factor receptors; connective tissue growth factor; huchordin; embryonic development; inhibitor of myeloid or lymphoid progenitor cell proliferation |
| 07/03/2003 | US20030125539 DNA encoding SNORF25 receptor |
| 07/03/2003 | US20030125538 Amino acid transporters and uses |
| 07/03/2003 | US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 07/03/2003 | US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines |
| 07/03/2003 | US20030125535 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030125528 Comprises porcine somatotropin and o-vanillin, for improving feed efficiency in swine; opioid analgesics; freeze drying, spray drying; storage stabiity |
| 07/03/2003 | US20030125524 Fusion proteins; interleukins; colony stimulating factors; cellular proliferation/differentiation; culturing bone marrow or peripheral blood cells; natural killer cells |
| 07/03/2003 | US20030125523 Novel neuropilin/growth factor complexes and uses thereof |
| 07/03/2003 | US20030125522 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| 07/03/2003 | US20030125521 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 07/03/2003 | US20030125520 Novel hemopoietin receptor protein, NR10 |
| 07/03/2003 | US20030125519 Ligand for the c-kit receptor and methods of use thereof |
| 07/03/2003 | US20030125518 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 07/03/2003 | US20030125517 Lipopeptides; virosomal delivery systems for transporting drugs, nucleic acids and proteins |
| 07/03/2003 | US20030125516 Preparing T-1249 and T-1249-like amino acid sequences; viricides |
| 07/03/2003 | US20030125515 Endcapped genetically engineered human immunodeficiency viral polypeptides; viricides |
| 07/03/2003 | US20030125296 Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes |
| 07/03/2003 | US20030125295 Novel nucleic acid and amino acid sequences |
| 07/03/2003 | US20030125294 Selective toxin expression in angiogenic endothelial cells |
| 07/03/2003 | US20030125286 Transcriptional silencer protein NRF |
| 07/03/2003 | US20030125285 Method of examining efficacy of therapy with nucleic acid |
| 07/03/2003 | US20030125282 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER) |
| 07/03/2003 | US20030125269 T-type calcium channel |
| 07/03/2003 | US20030125263 Nucleic acid ligand complexes |
| 07/03/2003 | US20030125262 Methods and reagents for regulation of cellular responses in biological systems |
| 07/03/2003 | US20030125258 Bone polypeptide-1 |
| 07/03/2003 | US20030125257 A olilgopeptide or polypeptide containing Leustatin, Chastatin or Tyrstatin |
| 07/03/2003 | US20030125253 Novel protein, process for producing the same and use therof |
| 07/03/2003 | US20030125249 Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes |
| 07/03/2003 | US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125246 Respiratory system related polynucleotides and the polypeptides encoded by these polynucleotides known as respiratory system antigens useful for detecting cancer or cancer metastases of respiratory system tissues |
| 07/03/2003 | US20030125245 Compositions and methods for therapy and diagnosis of lung cancer |
| 07/03/2003 | US20030125242 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 07/03/2003 | US20030125238 Hemoglobin-based oxygen carriers are prepared by reacting hemoglobin with oxidatively ring-opened polysaccharides such as hydroxyethyl starch or dextran, and storing the resultant conjugate under conditions which allow it to transform to a |
| 07/03/2003 | US20030125232 Stabilized proteins with engineered disulfide bonds |
| 07/03/2003 | US20030125230 Compositions for maintaining the integrity of the gastrointestinal tract luminal lining in a mammal, including (1) limiting epithelial cell proliferation, (2) inhibiting ulcerative lesion formation, (3) inhibiting inflammation |
| 07/03/2003 | US20030124741 Serine substituted gold inserted apoferritin; transport proteins; for use in producing semiconductors |
| 07/03/2003 | US20030124726 Detecting modulator of inflammatory response; antiinflammatory agents; cell surface receptors; fibronectins; antiarthritic agents; bronchodilator agents |
| 07/03/2003 | US20030124723 Use of a nuclease inhibitor or interleukin-10 (IL-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 07/03/2003 | US20030124718 Cytolytic T lymphocyte (CTL); viricides; particle acceleration apparatus |
| 07/03/2003 | US20030124708 Modification of virus tropism and host range by viral genome shuffling |
| 07/03/2003 | US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents |
| 07/03/2003 | US20030124703 Removal of plasmin(ogen) from protein solutions |
| 07/03/2003 | US20030124690 Novel compounds |
| 07/03/2003 | US20030124689 Mitomycin biosynthetic gene cluster |
| 07/03/2003 | US20030124687 LysE proteins; fermentation; animal feeds; dihydrodipicolinate synthases; amino acid biosynthesis |
| 07/03/2003 | US20030124678 Interleukin-2 mutants with reduced toxicity |
| 07/03/2003 | US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 07/03/2003 | US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA |
| 07/03/2003 | US20030124672 Opioid receptor genes |